(redirected from myeloma cell)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.
Related to myeloma cell: hybridoma

CELL. A small room in a prison. See Dungeon.

A Law Dictionary, Adapted to the Constitution and Laws of the United States. By John Bouvier. Published 1856.
References in periodicals archive ?
Silvestris et al., "Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells," Clinical and Experimental Immunology, vol.
Hu et al., "Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779," Cancer
The optimum ratios of DNA and transfection reagents obtained for a number of cell lines, including two of the myeloma cell lines (SP2/0 and Ag8) were found to be 2 [micro]l/4 [micro]l, 2 [micro]g/2[micro]l and 0.5 [micro]g/ 25 [micro]1 using jctPEI, Lipofectamine2000 and LyoVec, respectively (data not presented).
There is evidence that the p38 pathway indirectly promotes the growth of MM cells in response to growth factors of myeloma cells (such as IL-6, IL-10, insulin-like growth factor 1, and granulocytic colony-stimulating factor).
An antibody against DKK1 is now being tested in clinical trials after showing promise by improving bone disease and inhibiting myeloma cell growth in a murine model [125].
In our study, we found that the NF-[kappa]B-94 ins/del ATTG polymorphism is not a susceptible factor for MM, but MM patients with the NF-[kappa]B-94 ins/del ATTG del/del genotype had the highest myeloma cell ratio compared with ins/ins and ins/del patients.
A hybridoma C4H5 cell line was developed by the fusion of Sp2/0 myeloma cells with spleen cells that were harvested from Balb/c mice immunized with complete DA antigen.
Shalev et al., "Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via [[alpha].sub.v][[beta].sub.3] integrin in myeloma cells," Oncotarget, vol.
Davies et al., "Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration," Blood, vol.
Bataille et al., "A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines," Haematologica, vol.
Mouse myeloma cells SP2/0 (ATCC number CRL-1581[TM]) were fused with human B-cells following the methods of Kohler and Milstein [19] and Ostberg and Pursch [20] with modifications in details.